official notice
decision of a delegate of the commissioner of patents
Application : No. 16397/92 in the name of AMERICAN HOME PRODUCTS CORPORATION
Title: Process and intermediates for making isoquinoline derivatives
Action: Hearing in relation to objections during examination
Decision: Issued .
Abstract: Requirements for novelty and inventive step of compounds per se discussed.
Novelty of compounds assessed by considering:
- was the citation published before the priority date of the application under examination;
- what are the essential features of the invention as claimed;
- what is disclosed by the citation (what is clearly and unmistakably disclosed, and does the disclosure enable the preparation of the compounds); and
- is the application a selection?
Claims to intermediate compounds found to possess an inventive step but to be not novel.
patents act 1990
decision of a delegate of the commissioner of patents
Re:Patent Application No. 16397/92 by American Home Products Corporation, and objections raised by the Commissioner during examination.
background
Patent application 16397/92, which is entitled "Process and intermediates for making isoquinoline derivatives" was filed on 20 May 1992. The applicant and nominated person is American Home Products Corporation. The application claims priority from a United States application (having a priority date of 22 May 1991) and a United Kingdom application (having a priority date of 8 April 1992).
A first examination report, raising only the issue of novelty, was issued on 2 August 1993. This objection was maintained in the light of argument from the patent attorney for the applicant. After the third adverse report, the applicant requested a hearing. The applicant was then notified (in a fourth adverse report) that there was also an inventive step objection.
The hearing was held in Canberra on 1 July 1994. The applicant was represented by Mr Paul Kilborn (patent attorney of Phillips Ormonde & Fitzpatrick, Melbourne).
the specification
The specification commences with the statement:
"The present invention relates to a process for the preparation of spiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones which are useful as aldose reductase inhibitors. The invention also relates to novel intermediates useful in the process."
The admitted prior art reveals that spiro-isoquinolinepyrrolidines are known to be useful as aldose reductase inhibitors. The problem addressed by the specification is to improve the yield for the preparation of spiro-isoquinoline-pyrrolidines.
The specification relates specifically to a process for the preparation of compounds having the formula:
(II)
in which R1 is hydrogen or halogen and R2 is methyl or dihalogen-substituted benzyl.
The compounds of formula (II) are prepared by the following process:
The specification ends with 15 claims. The key claim is claim 10, which reads as follows:
"10.A nitrile having the formula
(IV)
wherein R1, R2 and -CO2R3 are as defined in claim 1."
The variables R1, R2 and -CO2R3 are defined in claim 1 in the following terms: "R1 is hydrogen or halogen and R2 is methyl or dihalogen-substituted benzyl", and "-CO2R3 is an ester group".
Claims 11, 12, and 15 are appended to claim 10. They read as follows:
Keep reading for free
Create a free CaseChat account to read AMERICAN HOME PRODUCTS CORPORATION and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1994] APO 58
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.